Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00317291 |
This is a sample-size-limited, randomized, blinded (subject and evaluator), sham acupuncture/placebo moxibustion (sham acu/placebo moxa) controlled clinical trial. The subjects in this study will be 50 men and women with HIV infection who have a diagnosis of distal symmetric peripheral neuropathy (DSP). Subjects will be randomized to one of two experimental intervention conditions:
All subjects in Conditions 1 and 2 will attend 16 scheduled sessions over 15 weeks, be administered the same instruments, and submit their daily symptom diaries for analysis. There will be six weeks of twice weekly treatment sessions, and three follow-up sessions at weeks 9, 11, and 15. All conditions will be identical in duration and be administered by licensed acupuncturists trained in traditional Chinese medicine (TCM).
Condition | Intervention | Phase |
---|---|---|
Peripheral Neuropathies HIV Infections |
Procedure: Acupuncture/Moxibustion |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Acu/Moxa for Peripheral Neuropathy in Persons With HIV |
Estimated Enrollment: | 50 |
Study Start Date: | November 2005 |
Estimated Study Completion Date: | June 2008 |
Subjects in this early-phase clinical trial will be 50 men and women with HIV infection who have a diagnosis of Distal Symmetric Peripheral neuropathy (DSP). This study is a prospective, randomized, sham/placebo controlled, blinded (subject and evaluator), parallel groups clinical trial. Subjects will be randomized to one of two experimental intervention conditions:
Subjects in Conditions 1 and 2 will attend 16 scheduled sessions over 15 weeks. All subjects will: be blinded/masked to treatment assignments, attend the same number of protocol sessions, be administered the same instruments, and submit their symptom diaries for data entry and analysis. After a screening/intake session, randomization and treatment sessions will follow. There will be six weeks of twice weekly treatment sessions, and three follow-up sessions at weeks 9, 11 and 15. All conditions will be identical in duration and be administered by licensed acupuncturists trained in Traditional Chinese Medicine. The aims of this study include:
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Ann M Chung | 212-305-3041 | amc103@columbia.edu |
Contact: Debra Narcisse, MSN | 212-305-3041 |
United States, New York | |
Columbia University School of Nursing, Acupuncture Laboratory | Recruiting |
New York, New York, United States, 10032 | |
Contact: Ann M Chung 212-305-3041 amc103@columbia.edu | |
Contact: Debra A Narcisse, MSN 212-305-3041 | |
Principal Investigator: Joyce K Anastasi, PhD, DrNP |
Principal Investigator: | Joyce K Anastasi, PhD, DrNP | Columbia University |
Study ID Numbers: | R21 AT003092, AAAB4122 |
Study First Received: | April 20, 2006 |
Last Updated: | November 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00317291 |
Health Authority: | United States: Federal Government |
Acupuncture HIV AIDS Symptom management |
Non-invasive Complementary Therapies Treatment Experienced |
Virus Diseases Sexually Transmitted Diseases, Viral Neuromuscular Diseases HIV Infections Peripheral Nervous System Diseases |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases |
Nervous System Diseases Lentivirus Infections Infection |